¿Cómo podría ser el futuro de los medicamentos recetados bajo la administración de Trump?
Former President Donald Trump’s return to the White House is expected to bring changes to various aspects of the healthcare sector, including reproductive care, federal insurance programs, and prescription drugs. Industry experts, including pharmaceutical executives and healthcare consultants, anticipate that the upcoming Trump administration will impact the prescription drug landscape, particularly in areas such as … Leer más